Assura PLC — Board/Management Information 2016

Jun 14, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0626B

Assura PLC

14 June 2016

14 June 2016

Assura plc

Update statement regarding Graham Roberts

On 4 March 2016 Assura plc announced that Graham Roberts was taking a leave of absence to receive treatment for his cancer. This treatment remains ongoing and Graham now believes that he needs to focus all his energies on his further treatment and recovery, so has therefore decided to step down as CEO with immediate effect.

The Board will now commence a process to appoint a replacement CEO. As announced in March, Simon Laffin has stepped up to be Executive Chairman of Assura and will continue to do so until this process is complete.

Graham Roberts, said;

'I am very proud of what we have achieved since I became CEO of Assura in establishing the business as the leading provider of primary care property in the UK today. This is a great example of a company that has both supported local communities and created substantial value for the shareholders. We have built a first class management team and I leave the business in very capable hands. I wish them all every success in delivering the next chapter in the Assura story.'

Simon Laffin, commented;

'Graham has been a great leader and CEO to this business over the past four years, delivering a period of unparalleled success which has seen the market capitalisation increase from £152m to become a FTSE 250 company valued at over £900m. All of us are greatly saddened by Graham's illness and resignation, and wish him well. He has left a business in great shape with a fine team. We shall continue to grow Assura and support NHS primary care in the UK.'

- Ends -

For more information, please contact:

Assura plc	Tel: 01925 420660
Simon Laffin, Executive Chairman Orla Ball, Company Secretary
Finsbury	Tel: 0207 251 3801
Gordon Simpson

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111 million.

Further information is available at www.assuraplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUOVNRNRANAAR